Bristol-Myers Squibb Company or BMS ( BMY ) released its first quarter (Q1 2025) numbers yesterday, which aren't bad at all. But can they mark a break from the stock's sagging performance over the past month?Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment banking. She also runs the profile Long Term Tips [LTT], which focuses on the generational opportunity in the green economy. Her investing group, Green Growth Giants , tak ...